Thursday, September 09, 2021 4:24:00 PM
Developing CAR-T Cells for Multiple Myeloma: From Autologous to Allogeneic https://poseida.com/wp-content/uploads/2021/08/Matt-Spear_BCMA-CAR-TCR21-final-210831.pdf
Advancing Nonviral Manufacturing for Multi-Product Allogeneic T-Cell Therapies https://poseida.com/wp-content/uploads/2021/09/210901-Shedlock-CAR-TCR-Summit-2.pdf
Developing piggyBac Systems “Off-the-Shelf” CAR-T Cells for Bone Marrow Transplant Conditioning https://poseida.com/wp-content/uploads/2021/08/Nina-Timberlake_20210902-CAR-TCR-Beyond-Oncology.pdf
Recent PSTX News
- Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-ALLO1 to Treat Relapsed/Refractory Multiple Myeloma • PR Newswire (US) • 09/16/2024 12:00:00 PM
- Poseida Therapeutics to Present New Clinical Data from Phase 1 Study of Allogeneic CAR-T P-BCMA-ALLO1 in Patients with Relapsed/Refractory Multiple Myeloma at 21st International Myeloma Society Annual Meeting • PR Newswire (US) • 09/05/2024 01:00:00 PM
- Poseida Therapeutics Presents New Case Study Demonstrating Reactivation of CAR-T Therapy with a T-Cell Engager in a Patient with Relapsed Multiple Myeloma • PR Newswire (US) • 09/04/2024 08:05:00 PM
- Poseida Therapeutics to Present at Upcoming Investor Conferences • PR Newswire (US) • 08/29/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/15/2024 04:15:10 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/05/2024 08:33:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 08:10:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:05:24 PM
- Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2024 • PR Newswire (US) • 08/05/2024 08:05:00 PM
- Poseida Therapeutics Announces Participation in Stifel's 2024 Virtual Cell Therapy Forum • PR Newswire (US) • 07/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:12:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:10:58 PM
- Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders • PR Newswire (US) • 06/03/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:11:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:06:16 PM
- Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 • PR Newswire (US) • 05/14/2024 08:05:00 PM
- Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting • PR Newswire (US) • 05/09/2024 01:00:00 PM
- Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology • PR Newswire (US) • 05/02/2024 01:30:00 AM
- Biotech Soars on Research Collaboration And License Agreement Release • AllPennyStocks.com • 05/01/2024 07:25:00 PM
- Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology • PR Newswire (US) • 05/01/2024 01:00:00 PM
- Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting • PR Newswire (US) • 04/18/2024 12:00:00 PM
- Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus • PR Newswire (US) • 04/17/2024 01:00:00 PM
- Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma • PR Newswire (US) • 04/08/2024 04:00:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM